Literature DB >> 33247584

Activities of daily living at hospital admission and estimated survival time of older patients.

Jesper Ryg1,2, Henriette Engberg3,4, Pavithra Laxsen Anru3,4, Solvejg Gram Henneberg Pedersen5, Martin Gronbech Jorgensen6, Kirsten Laila Vinding7,8, Tahir Masud1,2,9, Karen Andersen-Ranberg1,2.   

Abstract

BACKGROUND: Predicting expected survival time in acutely hospitalised older patients is a clinical challenge.
OBJECTIVE: To examine if activities of daily living (ADL) assessed by Barthel-Index-100 (Barthel-Index) at hospital admission adds useful information to clinicians on expected survival time in older patients.
METHODS: A nationwide population-based cohort study was used. All patients aged ≥65 years in the National Danish Geriatric Database from 2005 to 2014 were followed up until death, emigration or study termination (31 December 2015). Individual data were linked to national health registers. Barthel-Index was categorised into five-point subcategories with a separate category of Barthel-Index = 0. Kaplan-Meier analysis was used to assess crude survival proportions (95% CI) and Cox regression to examine association of Barthel-Index and mortality adjusting for age, Charlson comorbidity index, medication use, BMI, marital status, prior hospitalisations and admission year.
RESULTS: In total, 74,589 patients (63% women) aged (mean (SD)) 82.5(7.5) years with Barthel-Index (median (IQR)) 54(29-77) were included. In patients with Barthel-Index = 100-96 crude survival was 0.96(0.95-0.97) after 90-days, 0.88(0.87-0.89) after 1-year, and 0.79(0.78-0.80) after 2-years. Corresponding survival in patients with Barthel-Index = 0 was 0.49(0.47-0.51), 0.35(0.34-0.37) and 0.26(0.24-0.27). Decreasing Barthel-Index was associated with increasing mortality in the multivariable analysis. In women with Barthel-Index = 0, the mortality risk (HR (95% CI)) was 14.74(11.33-19.18) after 90-days, 8.40(7.13-9.90) after 1-year and 6.22(5.47-7.07) after 2-years using Barthel-Index = 100-96 as reference. In men, the corresponding risks were 11.36(8.81-14.66), 6.22(5.29-7.31) and 5.22(4.56-5.98).
CONCLUSIONS: ADL measured by Barthel-Index provides useful, easily accessible and independent information to clinicians on expected survival time in patients admitted to a geriatric department.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Barthel Index; activities of daily living; cohort study; geriatric patients; mortality

Mesh:

Year:  2021        PMID: 33247584     DOI: 10.1093/ageing/afaa251

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  4 in total

1.  Older patients acutely admitted and readmitted to the same geriatric department: a descriptive cohort study of primary diagnoses and health characteristics.

Authors:  Alexander Viktor Eriksen; Mikkel Dreier Thrane; Lars Matzen; Jesper Ryg; Karen Andersen-Ranberg
Journal:  Eur Geriatr Med       Date:  2022-07-28       Impact factor: 3.269

2.  Assessment of Activities of Daily Living in Post-cardiac Care Unit Using Barthel and Katz Indexes: A Cross-sectional Study.

Authors:  Farzane Khalandi; Mehryar Yoldashkhan; Homayoon Bana Derakhshan; Malihe Nasiri
Journal:  J Caring Sci       Date:  2022-01-10

3.  Prediction of Mortality in Older Hospitalized Patients after Discharge as Determined by Comprehensive Geriatric Assessment.

Authors:  Chih-Hsuan Su; Shih-Yi Lin; Chia-Lin Lee; Chu-Sheng Lin; Pi-Shan Hsu; Yu-Shan Lee
Journal:  Int J Environ Res Public Health       Date:  2022-06-24       Impact factor: 4.614

4.  Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study.

Authors:  Søren Ramsdal Sørensen; Jeppe Dalskov Frederiksen; Pavithra Laxsen Anru; Tahir Masud; Mirko Petrovic; Jens-Ulrik Rosholm; Jesper Ryg
Journal:  Drugs Real World Outcomes       Date:  2021-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.